Down-regulation of IFN-γ-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 7, 2005, Pages 2458-2464

  Ahn, Jae Kyoun ^a   Seo, Jong Mo ^a   Yu, Jeesuk ^b   Oh, Frederick Sehwoong ^a   Chung, Hum ^a   Yu, Hyeong Gon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PREDNISONE; TRIAMCINOLONE; CD56 ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AQUEOUS HUMOR; ARTICLE; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LYMPHOCYTE SUBPOPULATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE; UVEITIS; BLOOD; DRUG COMBINATION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD56; BEHCET SYNDROME; CYCLOSPORINE; DOWN-REGULATION; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 23244433266     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0792     Document Type: Article

References (36)

1. Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol. 2001;46:209-233.
2. Direskeneli H. Behçet's disease: infectious etiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996-1002.
3. Mizuku N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702-3708.
4. Kitaichi N, Kotake S, Sasamoto Y, et al. Prominent increase of macrophage inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci. 1999;40:247-250.
5. Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin-6, IL-8, and increased neutrophil superoxide generation in Behçet's disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544-1549.
6. Kurhan-Yavuz S, Direskeneli H, Bozkurt N, et al. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol. 2000;120:162-166.
7. De Smet MD, Dayan M. Prospective determination of T cell responses to S-antigen in Behçet's disease patients and control subjects. Invest Ophthalmol Vis Sci. 2000;41:3480-3484.
8. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenic role of interleukin-12. Arthritis Rheum. 1999;42: 1967-1974.
9. Yu HG, Lee DS, Seo JM, et al. The numbers of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis. Clin Exp Immunol. 2004;137:437-443.
10. Hamzaoui K, Hamzaoui A, Hentati F, et al. Phenotype and functional profile of T cells expressing gammadelta receptor from patients with active Behçet's disease. J Rheumatol. 1994;21:2301-2306.
11. Lanier LL, Testi R, Bindl J, Philips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989;169:2233-2238.
12. Satoh M, Seki S, Hashimoto W, et al. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol. 1996;157:3886-3892.
13. Ou D, Metzger DL, Wang X, Pozzilli P, Tingle AJ. β-cell antigen-specific CD56+ NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56+ β cells by HLA-restricted and non-HLA-restricted pathways. Hum Immunol. 2002;63:256-270.
14. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol. 1995;13:251-276.
15. Dick AD, Azim M, Forrester JV. Immunosuppressive therapy for chronic uveitis, optimizing therapy with steroid and cyclosporine A. Br J Ophthalmol. 1997;81:1107-1112.
16. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Ann Rev Immunol. 1997;15:707-747.
17. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Increased frequencies of interleukin-2 and interferon-gamma producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci. 1998;42:996-1004.
18. Behçet's Disease Research Committee of Japan. Guide to diagnosis of Behçet's disease. Jpn J Ophthalmol. 1974;18:291-293.
19. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods. 1993;159:197-207.
20. Yato H, Matsumoto Y. CD56+ T cells in the peripheral blood of uveitis patients. Br J Ophthalmol. 1999;83:1386-1390.
21. Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T. Increased CD4+ CD16+ and CD4+ CD56+ T-cell subsets in Behçet's disease. Rheumatology Int. 1999;19:23-26.
22. El-Shabrawi Y, Livir-Rallatos C, Christen W, et al. High level of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. Ophthalmology. 1998;105:1659-1663.
23. Rufer N, Zippellus A, Batard P, et al. Ex vivo characterization of human CD8+ T-cell subsets with distinct replicative history and partial effector functions. Blood. 2003;102:1779-1787.
24. Trautmann A, Ruckert B, Schmid-Grendelmeier P, et al. Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology. 2003;108:305-312.
25. Snyder MR, Weyand CM, Goronzy JJ. The double life of NK receptors: stimulation or co-stimulation? Trend Immunol. 2004; 25:25-32.
26. Frassanito MA, Dammacco R, Fusaro T, et al. Combined cyclosporine-A/ prednisone therapy of patients with active uveitis suppresses IFN-γ production and the function of dendritic cells. Clin Exp Immunol. 2003;133:233-239.
27. Roth E, Pircher H. IFN-γ promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol. 2004;172:1588-1594.
28. Yamaoka J, Kabashima K, Kawanishi M, Toda K, Miyachi Y. Cytotoxicity of IFN-γ and TNF-α for vascular endothelial cell is mediated by nitric oxide. Biochem Biophys Res Commun. 2002;291: 780-786.
29. Takayama E, Koike Y, Ohkawa T, et al. Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural kill cell markers, CD56+CD57- T cells, CD56+CD57+ T cells and CD56- CD57+ T cells. Immunology. 2003;108:211-219.
30. Zierhut M, Mizuki N, Ohno S, et al. Human Genome and Disease: Review, immunology and functional genomics of Behçet's disease. Cell Mol Life Sci. 2003;60:1903-1922.
31. Raziuddin S, Al-Bahlaan A, Bahabri S, et al. Divergent cytokine production profile in Behçet's disease: altered Th1/Th2 cell cytokine pattern. J Rheumatol. 1998;25:329-333.
32. Misumi M, Hagiwara E, Takeno M, et al. Cytokine production profile in patients with Behçet's s disease treated with infliximab. Cytokine. 2003;24:210-218.
33. Sakane T, Kotani H, Takada S, Tsunematsu T. Functional aberration of T-cell subsets in patients with Behçet's disease. Arthritis Rheum. 1982;25:1343-1351.
34. Bank I, Duvdevani M, Livneh A. Expansion of γδ T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med. 2003;141:33-40.
35. Freysdottir J, Lau SH, Fortune F. γδ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol. 1999;118:451-457.
36. Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med. 1984;77:652-656.